期刊文献+

一种新型乙型肝炎病毒RNA定量检测方法的临床检测性能评估 被引量:4

Evaluation of clinical utility of a novel method for quantitative detection of hepatitis B virus RNA
原文传递
导出
摘要 目的评估一种新型乙型肝炎病毒(hepatitis B virus,HBV)RNA定量检测方法——HBV实时荧光核酸恒温扩增检测(simultaneous amplification and testing,SAT)(RNA捕获探针法)的临床检测性能。方法采用简单随机抽样法收集2017年6月至2018年6月上海复旦大学附属华山医院收治的170例慢性乙型肝炎患者和30例非HBV感染者的血清标本HBV RNA,使用HBV SAT与常规反转录聚合酶链反应(polymerase chain reaction,PCR)进行检测,对两种方法检测的灵敏度、特异度、к值及定量值相关性进行比较,并对两种方法检测的不同HBV DNA浓度样本的检出率进行分析比较。统计学分析采用χ^2检验。结果以临床诊断为标准,HBV SAT检测灵敏度为97.06%(165/170),特异度为100.00%(30/30),κ值为0.908;反转录PCR检测灵敏度为92.94%(158/170),特异度为100.00%(30/30),κ值为0.798。在HBV DNA低浓度样本(HBV DNA<100 IU/mL)中,HBV SAT检出率为77.27%(17/22),反转录PCR检出率为59.09%(13/22)。两种方法定量结果线性相关系数r=0.9878。结论全自动HBV SAT与反转录PCR定量结果一致,在HBV DNA低浓度样本中的检测灵敏度比反转录PCR方法略高,是一种快速、准确的HBV RNA定量检测方法。 Objective To evaluate the clinical utility of a novel quantitative assay named hepatitis B virus(HBV)simultaneous amplification and testing(SAT)using a kit for HBV RNA detection(RNA probes).Methods HBV RNA was detected in 170 serum samples of chronic hepatitis B patients and 30 serum samples of patients without HBV infection collected by simple random sampling method from June 2017 to June 2018 in Huashan Hospital,Fudan University,Shanghai using HBV SAT and reverse transcription polymerase chain reaction(PCR)method.The sensitivity,specificity,kappa value and quantitative correlation of the two methods were analyzed and compared.The detection rates of HBV RNA from samples with different HBV DNA concentrations of the two methods were analyzed and compared.Statistical analysis was performed by chi-square test.Results Based on the clinical diagnosis,the detection sensitivity,specificity,kappa value of HBV SAT were 97.06%(165/170),100.00%(30/30)and 0.908,respectively,while the reverse transcription PCR were 92.94%(158/170),100.00%(30/30)and 0.798,respectively.Among samples with lower concentration of HBV DNA(HBV DNA<100 IU/mL),the detection rates of HBV SAT and reverse transcription PCR were 77.27%(17/22)and 59.09%(13/22),respectively.The linear correlation coefficient of the two methods was r=0.9878.Conclusions Quantitation results of HBV RNA by HBV SAT and reverse transcription PCR method are consistent.HBV SAT is a rapid and accurate method for HBV RNA quantitative detection,which has a slightly higher detection rate than reverse transcription PCR in samples with low concentration of HBV DNA.
作者 张缈曲 张琪然 张寒悦 喻一奇 仇超 张文宏 Zhang Miaoqu;Zhang Qiran;Zhang Hanyue;Yu Yiqi;Qiu Chao;Zhang Wenhong(Department of Infections Diseases,Huashan Hospital,Fudan University,Shanghai 200040,China)
出处 《中华传染病杂志》 CAS CSCD 2020年第12期782-785,共4页 Chinese Journal of Infectious Diseases
基金 十三五"艾滋病和病毒性肝炎等重大传染病防治"科技重大专项(2017ZX10302201-006-003)。
关键词 肝炎病毒 乙型 RNA 定量检测 Hepatitis B virus RNA Quantitative detection
  • 相关文献

参考文献4

二级参考文献30

  • 1Kock J, Theilmann L, Galle P, et al. Hepatitis B vires nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus[J].Hepatology, 1996, 23(3): 405-413.
  • 2Jansen L, Kootstra NA, van Dort KA, et al. Hepatitis B virus pregenomic RNA is present in virions in plasma and is associated with a response to pegylated interferon alfa-2a and nucleos(t)ide analogues[J]. J Infect Dis, 2016, 213(2): 224-232. DOI: 10.1093/ infdis/jiv397.
  • 3Tsuge M, Murakami E, Imamura M, et al. Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients[J]. J Gastroenterol, 2013, 48(10): 1188-1204. DOI: 10.1007/s00535-012-0737-2.
  • 4van Bfmmel F, Barrens A, Mysickova A, et al. Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors[J]. Hepatology, 2015, 61(1): 66-76. DOI: 10.1002/ hep.27381.
  • 5Wang J, Shen T, Huang X, et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound[J]. J Hepatol, 2016 May 28. pii: S0168-8278(16)30241-0. DOI: 10.1016/j.jhep.2016.05.029.
  • 6Sung WK, Zheng H, Li S, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma[J]. Nat Genet, 2012, 44(7): 765-769. DOI: 10.1038/ng.2295.
  • 7Jiang S, Yang Z, Li W, et al. Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis[J]. PLoS One, 2012, 7(9): e40363. DOI: 10.1371/journal.pone.0040363.
  • 8Li X, Zhang J, Yang Z, et al. The function of targeted host genes determines the oncogenicity of HBV integration in hepatocellular carcinoma[J]. J Hepatol, 2014, 60(5): 975-984. DOI: 10.1016/ j.jhep.2013.12.014.
  • 9Shouval D, Rager-Zisman B, Quan P, et al. Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus[J]. J Clin Invest, 1983, 72(2): 707-717.
  • 10Shouval D, Reid LM, Chakraborty PR, et al.Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA[J]. Cancer Res, 1981, 41(4): 1342-1350.

共引文献284

同被引文献28

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部